Must See: Do You Invest in Midcap Stocks? Here's a Great News for You
Here is the latest financial fact sheet of SEQUENT SCIENTIFIC. For more details, see the SEQUENT SCIENTIFIC quarterly results and SEQUENT SCIENTIFIC share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.8 |
No. of shares | m | 249.43 |
1 Week | % | -2.0 |
1 Month | % | 1.9 |
1 Year | % | 74.2 |
52 week H/L | Rs | 155.5/69.8 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SEQUENT SCIENTIFIC EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 89 | 99 | 265 | 336 | 156 | |
Low | Rs | 42 | 52 | 70 | 121 | 62 | |
Sales per share (Unadj.) | Rs | 42.1 | 47.5 | 54.8 | 56.9 | 57.0 | |
Earnings per share (Unadj.) | Rs | 2.3 | 3.3 | 4.2 | 1.8 | -4.9 | |
Diluted earnings per share | Rs | 2.3 | 3.3 | 4.2 | 1.8 | -4.9 | |
Cash flow per share (Unadj.) | Rs | 4.0 | 5.3 | 6.2 | 3.9 | -2.7 | |
Dividends per share (Unadj.) | Rs | 0.20 | 0 | 0.50 | 0 | 0 | |
Adj. dividends per share | Rs | 0.20 | 0.00 | 0.50 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0.3 | 0 | 0.3 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 27.9 | 27.1 | 29.0 | 26.0 | 25.8 | |
Adj. book value per share | Rs | 27.6 | 27.0 | 28.9 | 25.9 | 25.8 | |
Shares outstanding (eoy) | m | 246.87 | 248.37 | 248.37 | 248.37 | 249.43 | |
Price / Sales ratio | x | 1.6 | 1.6 | 3.1 | 4.0 | 1.9 | |
Avg P/E ratio | x | 28.5 | 22.9 | 39.8 | 126.9 | -22.3 | |
P/CF ratio (eoy) | x | 16.4 | 14.2 | 26.8 | 59.0 | -41.0 | |
Price / Book Value ratio | x | 2.4 | 2.8 | 5.8 | 8.8 | 4.2 | |
Dividend payout | % | 8.7 | 0 | 11.9 | 0 | 0 | |
Avg Mkt Cap | Rs m | 16,226 | 18,795 | 41,590 | 56,802 | 27,151 | |
Total wages/salary | Rs m | 1,459 | 1,651 | 1,872 | 2,314 | 2,584 |
SEQUENT SCIENTIFIC INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 10,393 | 11,792 | 13,616 | 14,128 | 14,209 | |
Other income | Rs m | 87 | 101 | 105 | 109 | 64 | |
Total revenues | Rs m | 10,480 | 11,893 | 13,721 | 14,237 | 14,273 | |
Gross profit | Rs m | 1,249 | 1,703 | 2,011 | 1,094 | -528 | |
Depreciation | Rs m | 419 | 506 | 506 | 515 | 557 | |
Interest | Rs m | 328 | 357 | 244 | 158 | 355 | |
Profit before tax | Rs m | 589 | 941 | 1,366 | 529 | -1,377 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 20 | 120 | 322 | 82 | -157 | |
Profit after tax | Rs m | 569 | 820 | 1,045 | 448 | -1,220 | |
Gross profit margin | % | 12.0 | 14.4 | 14.8 | 7.7 | -3.7 | |
Effective tax rate | % | 3.4 | 12.8 | 23.6 | 15.4 | 11.4 | |
Net profit margin | % | 5.5 | 7.0 | 7.7 | 3.2 | -8.6 |
SEQUENT SCIENTIFIC BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 6,061 | 7,243 | 7,667 | 8,084 | 8,125 | |
Current liabilities | Rs m | 4,404 | 5,149 | 5,131 | 5,374 | 5,588 | |
Net working cap to sales | % | 15.9 | 17.8 | 18.6 | 19.2 | 17.9 | |
Current ratio | x | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | |
Inventory Days | Days | 97 | 59 | 31 | 27 | 21 | |
Debtors Days | Days | 98 | 99 | 93 | 85 | 88 | |
Net fixed assets | Rs m | 7,960 | 7,389 | 6,763 | 6,782 | 7,435 | |
Share capital | Rs m | 494 | 497 | 497 | 497 | 499 | |
"Free" reserves | Rs m | 6,384 | 6,233 | 6,702 | 5,953 | 5,926 | |
Net worth | Rs m | 6,878 | 6,730 | 7,199 | 6,450 | 6,425 | |
Long term debt | Rs m | 1,478 | 1,501 | 937 | 1,225 | 1,828 | |
Total assets | Rs m | 14,021 | 14,632 | 14,430 | 14,866 | 15,661 | |
Interest coverage | x | 2.8 | 3.6 | 6.6 | 4.4 | -2.9 | |
Debt to equity ratio | x | 0.2 | 0.2 | 0.1 | 0.2 | 0.3 | |
Sales to assets ratio | x | 0.7 | 0.8 | 0.9 | 1.0 | 0.9 | |
Return on assets | % | 6.4 | 8.0 | 8.9 | 4.1 | -5.5 | |
Return on equity | % | 8.3 | 12.2 | 14.5 | 6.9 | -19.0 | |
Return on capital | % | 11.0 | 15.8 | 19.8 | 9.0 | -12.4 | |
Exports to sales | % | 0 | 2.7 | 5.0 | 2.2 | 1.8 | |
Imports to sales | % | 0 | 1.1 | 2.1 | 1.6 | 1.0 | |
Exports (fob) | Rs m | 0 | 316 | 686 | 311 | 255 | |
Imports (cif) | Rs m | 0 | 130 | 281 | 220 | 138 | |
Fx inflow | Rs m | 0 | 316 | 686 | 311 | 255 | |
Fx outflow | Rs m | 0 | 130 | 281 | 220 | 138 | |
Net fx | Rs m | 0 | 185 | 405 | 91 | 117 |
SEQUENT SCIENTIFIC CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,160 | 1,153 | 1,148 | 306 | 168 | |
From Investments | Rs m | -677 | -723 | 96 | -956 | -650 | |
From Financial Activity | Rs m | -201 | -428 | -1,388 | 673 | 322 | |
Net Cashflow | Rs m | 282 | 3 | -144 | 38 | -159 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Kamal K Sharma | COMP SEC: Krunal Shah | YEAR OF INC: 1985 | BSE CODE: 512529 | FV (Rs): 2 | DIV YIELD (%): - |
Read: SEQUENT SCIENTIFIC 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare SEQUENT SCIENTIFIC With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.